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ABSTRACT
Participants
 85 gay, bisexual and other men who 
have sex with men (MSM) 
 Average age 46 years (range: 25 - 72) 
 92% identified as gay/homosexual
 57% single, 41% in a long-term 
relationship
 35% employed full-time; 20% part-time
 73% born in Australia, 85% currently 
living in Australia
 Average year of HIV diagnosis:  1998
 100% currently on HAART, 62% 
reporting no current health problems 
nor side effects, 91% reporting 
undetectable viral load 
Procedure
HIV Stigma
 Assessed through Bunn et al.’s (2007) 
32-item HIV Stigma Scale
 Measures how stigmatised individuals 
feel in regard to living with HIV
Adherence
 Assessed using Adherence to Refills 
and Medications Scale (ARMS; 
Kripalani et al., 2009)
Depression
 Assessed using Patient Health 
Questionnaire (PHQ-9) 
 Measures depressive symptoms 
experienced in the last 2 weeks
Anxiety
 Measured using Generalized Anxiety 
Disorder Questionnaire (GAD-7; 
Spitzer et al., 2006)
 Assesses how much an individual has 
been bothered by anxiety symptoms in 
the last 2 weeks
Ethics approval was granted by Queensland 
University of Technology.  Participation was 
voluntary and anonymous, and participants 
provided informed consent 
METHOD
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RESULTS
Both models indicated that depression and anxiety significantly mediated HIV stigma 
and adherence however non-significant results were shown in each for HIV stigma 
directly mediating adherence. However, the depression model more strongly 
mediates adherence than the anxiety model. 
.
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The study examined whether the relationship between HIV stigma and medication 
adherence would be mediated by depression and anxiety among men who have sex 
with men (MSM) whom are living with HIV (PLWH). Participants completed an online 
survey that measured HIV stigma, medication adherence (using the ARMS) and 
symptoms of depression (Patient Health Questionnaire-9) and anxiety (Generalised 
Anxiety Disorder-7). Results indicated depression mediated the association between 
HIV stigma and medication adherence more strongly than anxiety.
Figure 1. Standardised coefficients for the 
depression mediational model.
INTRODUCTION
Previous Research
 Optimal self-management for PLWH includes adherence to highly active 
antiretroviral therapy (HAART) to adequately provide viral suppression (Weaver, 
Llabre, Duran, Antoni, Ironson, Penedo & Schneiderman, 2005). 
 PLWH experience higher rates of stigma and discrimination associated with their 
health status, which can adversely effect self management (Brondani, Donnelly & 
Postnikoff, 2016). 
 Understanding modifiable psychological factors that effect adherence is important 
in optimising health among people living with HIV.
HIV Stigma
 Is an attribute that discredits and brings a whole person down to a discounted 
person (Goffman, 1963).
 Research shows that HIV-related stigma greatly negatively impacts mental and 
physical health of PLWH (Logie & Gadalla, 2009).
Purpose of Study
 To examine the role of depression and anxiety in explaining potential differences in 
adherence regarding HIV stigma among MSM living with HIV.
Research Question
 To what extent does depression and anxiety mediate HIV stigma and adherence?  
Are either psychological phenomena of greater concern?
CONCLUSIONS
Implications:
1. Role of screening for and treat depression and anxiety among PLWH, which can 
impact on self management (e.g. medication adherence).  Improving adherence can 
result in treatment outcomes, including reducing viral load and onward transmission
2. Role of screening for depression and anxiety among PLWH.
3. Potential benefits of trying reduce HIV stigma (among MSM and wider community).
4. Role of psychological interventions to improve adherence, including psychosocial 
factors.
Recommendations for Future Research
 Research into stigma within MSM and the wider communities.
 Investigation of other psychological factors/resilience among MSM and PLWH.
 Effectiveness of screening and treatment for depression/anxiety among PLWH.
 Effectiveness of adherence interventions among PLWH.
 Training clinicians to be mindful of role that mental health plays on adherence and 
referring PLWH appropriately for treatment.
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Figure 1. Standardised coefficients for the 
anxiety mediational model.
BACKGROUND
Importance of HIV Research
HIV/AIDS still a significant health issue globally & in Australia
 Currently, worldwide 36.9 million people are living with HIV/AIDS (2.6 million are 
children).
 Estimated 34 Million people have died since the beginning of the AIDS pandemic
 Australia’s HIV transmission continues to be predominantly related to condomless
sexual contact between men. 
Unique Stressors
 HIV Positive diagnosis can cause significant emotional distress often associated 
with an altered self-view, revised view of the future and stigma (Gluhoski, 1996).
 Higher rates of mental health symptoms exhibited with an emphasis on anxiety and 
depression among PLWH (Bogart, Wagner, Galvan, Landrine, Klein & Sticklor 
(2011).
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